trending Market Intelligence /marketintelligence/en/news-insights/trending/oyiz5ELX7uHqCRS51yFFmw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

BioMed Realty buys Emeryville, Calif., life science office building for $135M

Street Talk Episode 61 - Investors debate if U.S. banks have enough capital in post COVID world

You Down With PPP? Consider The Risks

Street Talk Episode 60 - You Down With PPP? Consider The Risks

Gauging Supply Chain Risk In Volatile Times

BioMed Realty buys Emeryville, Calif., life science office building for $135M

Blackstone Group LP-backed BioMed Realty Trust Inc. paid approximately $135 million to acquire the Emeryville Center for Innovation.

The property in Emeryville, Calif., currently comprises a 250,000-square-foot, six-story life science office building with adjacent developable land parcels.

In connection with the deal, pharmaceutical company Novartis AG will enter into a one-year leaseback on the existing building. In that time, the office real estate investment trust will redevelop the building into a class A+ multi-tenant laboratory and office facility.

BioMed can develop about 850,000 square feet of additional laboratory and office space on the property through an existing development agreement with the city of Emeryville.